INNOVATION PHARMACEUTICALS
Innovation Pharmaceuticals is a publicly traded biopharmaceutical company dedicated to discovering and advancing innovative medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications.
INNOVATION PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2007-01-01
Address:
Beverly, Massachusetts, United States
Country:
United States
Website Url:
http://www.ipharminc.com
Total Employee:
11+
Status:
Active
Contact:
978-633-3623
Email Addresses:
[email protected]
Total Funding:
1000 K USD
Technology used in webpage:
IPv6 Google Apps For Business Google Maps Google Google Maps API ENom DNS OpenSRS
Similar Organizations
Actimis Pharmaceuticals
Actimis Pharmaceuticals is a biopharmaceutical company developing small molecule therapeutics for respiratory and inflammatory disorders.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Ception Therapeutics
Ception Therapeutics is a biopharmaceutical company developing novel products to address areas of unmet medical needs.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Quoin Pharmaceuticals
Quoin Pharmaceuticals is into developing products which address major unmet medical needs.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2013-09-09 | PolyMedix | PolyMedix acquired by Innovation Pharmaceuticals | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-15 | Squalus Medical | Innovation Pharmaceuticals investment in Corporate Round - Squalus Medical | N/A |
Official Site Inspections
http://www.ipharminc.com Semrush global rank: 1.61 M Semrush visits lastest month: 15.73 K
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Innovation Pharmaceuticals"
Welcome — Innovation Pharmaceuticals Inc.
WELCOME Whether you are a patient participating in one of our clinical trials, a member of the media, a shareholder, or a researcher or pharmaceutical industry executive interested in learning more about Innovation Pharma, here you will …See details»
Innovation Pharmaceuticals (IPIX) Company Profile & Description
Mar 19, 2025 Company profile for Innovation Pharmaceuticals Inc. (IPIX) with a description, list of executives, contact details and other key facts.See details»
Corporate Governance — Innovation Pharmaceuticals Inc.
CORPORATE GOVERNANCE Senior Management | Board of Directors The Board of Directors of INNOVATION PHARMACEUTICALS, INC. (the "Company") sets maximum standards for its …See details»
Corporate Overview - Squarespace
Corporate Overview 301 Edgewater Place, Ste 100, Wakefield, MA www.ipharminc.comSee details»
About INNOVATION PHARMACEUTICALS INC. | DxMultiomics
Innovation Pharmaceuticals is a publicly traded clinical stage biopharmaceutical company developing innovative therapies to address areas of unmet need. The Company also is active …See details»
Innovation Pharmaceuticals - Craft
Oct 29, 2024 Innovation Pharmaceuticals has 3 employees across 2 locations and $18 k in annual revenue in FY 2022. See insights on Innovation Pharmaceuticals including office …See details»
Innovation Pharmaceuticals - Overview, News & Similar
Jun 21, 2023 View Innovation Pharmaceuticals (www.ipharminc.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well …See details»
Innovation Pharmaceuticals (kfa Cellceutix) - VentureRadar
"Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to announce that the U.S. Food and Drug Administration (FDA) has …See details»
Contact Us — Innovation Pharmaceuticals Inc.
Innovation Pharmaceuticals (IPIX) is a publicly traded clinical stage biopharmaceutical company developing innovative therapies to address areas of unmet need. The Company also is active in evaluating other potential …See details»
SPharm Canada
Regulatory Expertise Matters Effective management of health product development plans, Clinical Trial Applications and obtaining marketing authorization in Canada requires …See details»
Innovation Pharmaceuticals Announces New Antifungal Testing
Mar 15, 2023 Innovation Pharmaceuticals Announces New Antifungal Testing of Brilacidin by NIH/NIAID-Affiliated and Other Academic Researchers March 15, 2023 08:00 ET | Source: …See details»
Innovation Pharmaceuticals Inc. Company Information - Simply …
Learn more about Innovation Pharmaceuticals Inc. (IPIX). From their employee growth over the years and their exchange listings.See details»
Innovation Pharmaceuticals, RBL trials nearing completion
Jun 25, 2020 BRILACIDIN, "Possibly" the most effective therapeutic, preventive, ever against virus and infections. Under development at US REGIONAL BIOCONTAINMENT LABS.See details»
Innovation Pharmaceuticals’ Brilacidin for the Treatment of
Jan 14, 2021 --Innovation Pharmaceuticals, a clinical stage biopharmaceutical company, is pleased to announce that the U.S. Food and Drug Administration has designated as a Fast …See details»
Scientific Advisors — Innovation Pharmaceuticals Inc.
Sonis also is a Founder and Chief Scientific Officer of Biomodels, LLC, a preclinical contract research organization. Widely respected by his professional peers, he is the author of over …See details»
Innovation Pharmaceuticals Announces BT BeaMedical …
WAKEFIELD, MA, Jan. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire– BT BeaMedical Technologies (“BeaMed”), a private company minority-owned by Innovation Pharmaceuticals …See details»
Innovation Pharmaceuticals Provides Update on Brilacidin
Feb 8, 2021 Innovation Pharmaceuticals Provides Update on Brilacidin Antiviral Research August 02, 2021 07:00 ET | Source: Innovation Pharmaceuticals Inc. FollowSee details»
Innovation Pharmaceuticals Announces New Milestone at BeaMed; …
WAKEFIELD, MA / August 28, 2023 Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company and minority stakeholder in BT BeaMed …See details»
Innovation Pharmaceuticals’ Phase 2 Clinical Trial of ... - Nasdaq
Jan 29, 2021 --Innovation Pharmaceuticals, a clinical stage biopharmaceutical company, announces today that the Company’ s Phase 2 clinical trial of Brilacidin for treating COVID-19 …See details»